• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估甲状腺功能减退症治疗满意度的新问卷(ThyTSQ)的心理测量学评价。

Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ.

作者信息

McMillan Carolyn, Bradley Clare, Razvi Salman, Weaver Jolanta

机构信息

Royal Holloway, University of London, Egham, Surrey, UK.

出版信息

Value Health. 2006 Mar-Apr;9(2):132-9. doi: 10.1111/j.1524-4733.2006.00091.x.

DOI:10.1111/j.1524-4733.2006.00091.x
PMID:16626417
Abstract

OBJECTIVES

There is a clinical impression of dissatisfaction with treatment for hypothyroidism among some patients. Psychometric properties of the new ThyTSQ questionnaire are evaluated. The questionnaire, measuring patients' satisfaction with their treatment for hypothyroidism, has two parts: the seven-item ThyTSQ-Present and four-item ThyTSQ-Past, measuring satisfaction with present and past treatment, respectively, on scales from 6 (very satisfied) to 0 (very dissatisfied).

METHODS

The questionnaire was completed once by 103 adults with hypothyroidism, age (mean [SD]) 55.2 [14.4], range 23-84 years (all treated with thyroxine).

RESULTS

Completion rates were very high. Internal consistency reliability was excellent for both ThyTSQ-Present and ThyTSQ-Past (Cronbach's alpha = 0.91 and 0.90, respectively [N = 102 and 103]). Principal components analyses indicated that the seven items of the ThyTSQ-Present and the four items of the ThyTSQ-Past could be summed into separate Present Satisfaction and Past Satisfaction total scores. Mean Present Satisfaction was 32.5 (7.8), maximum range 0-42, and mean Past Satisfaction was 17.5 (6.1), maximum range 0-24, indicating considerable room for improvement. Patients were least satisfied with their present understanding of their condition, mean 4.2 (1.7) (maximum range 0-6), and with information provided about hypothyroidism around the time of diagnosis, mean 3.9 (1.8) (maximum range 0-6).

CONCLUSIONS

The ThyTSQ is highly acceptable to patients with hypothyroidism (excellent completion rates), and has established internal consistency reliability. It will assist health professionals in considering psychological outcomes when treating people with hypothyroidism, and is suitable for clinical trials and routine clinical monitoring.

摘要

目的

部分患者对甲状腺功能减退症的治疗存在不满意的临床印象。对新的ThyTSQ问卷的心理测量特性进行评估。该问卷用于测量患者对甲状腺功能减退症治疗的满意度,分为两部分:七项的ThyTSQ-当前部分和四项的ThyTSQ-过去部分,分别测量对当前和过去治疗的满意度,评分范围为6分(非常满意)至0分(非常不满意)。

方法

103名成年甲状腺功能减退症患者(年龄[均值(标准差)]55.2 [14.4],范围23 - 84岁,均接受甲状腺素治疗)每人完成一次该问卷。

结果

问卷完成率非常高。ThyTSQ-当前部分和ThyTSQ-过去部分的内部一致性信度均极佳(Cronbach's α分别为0.91和0.90 [N = 102和103])。主成分分析表明,ThyTSQ-当前部分的七项和ThyTSQ-过去部分的四项可分别汇总为当前满意度总分和过去满意度总分。当前满意度均值为32.5(7.8),最大范围0 - 42,过去满意度均值为17.5(6.1),最大范围0 - 24,表明有很大的改进空间。患者对目前对自身病情的了解程度满意度最低,均值为4.2(1.7)(最大范围0 - 6),对诊断时提供的有关甲状腺功能减退症的信息满意度也最低,均值为3.9(1.8)(最大范围0 - 6)。

结论

ThyTSQ问卷在甲状腺功能减退症患者中接受度很高(完成率极佳),并已确立了内部一致性信度。它将有助于健康专业人员在治疗甲状腺功能减退症患者时考虑心理结果,适用于临床试验和常规临床监测。

相似文献

1
Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ.一种用于评估甲状腺功能减退症治疗满意度的新问卷(ThyTSQ)的心理测量学评价。
Value Health. 2006 Mar-Apr;9(2):132-9. doi: 10.1111/j.1524-4733.2006.00091.x.
2
Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism.用于测量甲状腺功能减退症患者生活质量和治疗满意度的新问卷设计。
Thyroid. 2004 Nov;14(11):916-25. doi: 10.1089/thy.2004.14.916.
3
Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ.评估甲状腺功能减退对生活质量和症状影响的新指标:甲状腺疾病生活质量量表(ThyDQoL)和甲状腺疾病症状自评量表(ThySRQ)。
Value Health. 2008 Mar-Apr;11(2):285-94. doi: 10.1111/j.1524-4733.2007.00232.x.
4
Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ. adequately 治疗的甲状腺功能减退症患者报告结局 - ThyDQoL、ThySRQ 和 ThyTSQ 德国版本的见解。
Health Qual Life Outcomes. 2013 Apr 23;11:68. doi: 10.1186/1477-7525-11-68.
5
Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.骨质疏松症患者治疗满意度问卷(OPSAT-Q)的心理测量学评估,这是一种评估绝经后妇女对双膦酸盐治疗满意度的新方法。
Health Qual Life Outcomes. 2006 Jul 11;4:42. doi: 10.1186/1477-7525-4-42.
6
Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.儿童复发性腹痛多维测量方法的开发:在三种环境下开展的基于人群的研究
Pediatrics. 2005 Feb;115(2):e210-5. doi: 10.1542/peds.2004-1412.
7
Development of a psychometric scale to assess satisfaction with dental care among Sri Lankans.开发一种心理测量量表以评估斯里兰卡人对牙科护理的满意度。
Community Dent Health. 2009 Sep;26(3):150-6.
8
Validation of the revised 10-item HIV Treatment Satisfaction Questionnaire status version and new change version.
Value Health. 2006 Sep-Oct;9(5):320-33. doi: 10.1111/j.1524-4733.2006.00121.x.
9
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).膀胱过度活动症治疗满意度问卷(OAB-SAT-q)的心理测量学验证
Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.
10
Cross-cultural adaptation, validity and psychometric properties of the Spanish version of the Dental Satisfaction Questionnaire.《牙科满意度问卷》西班牙语版本的跨文化适应性、效度和心理测量特性
Community Dent Health. 2014 Mar;31(1):44-9.

引用本文的文献

1
Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties.患者报告的药物治疗满意度测量指标:测量开发和测量特性的系统评价。
BMC Med. 2024 Sep 2;22(1):347. doi: 10.1186/s12916-024-03560-3.
2
Design of a treatment satisfaction measure for patients undergoing varicose vein treatment: Venous Treatment Satisfaction Questionnaire (VenousTSQ).用于治疗静脉曲张患者的治疗满意度测量工具的设计:静脉治疗满意度问卷(VenousTSQ)。
Br J Surg. 2023 Jan 10;110(2):200-208. doi: 10.1093/bjs/znac387.
3
Thyroid disease-specific quality of life questionnaires - A systematic review.
甲状腺疾病特异性生活质量调查问卷 - 系统评价。
Endocrinol Diabetes Metab. 2022 Sep;5(5):e357. doi: 10.1002/edm2.357. Epub 2022 Jul 20.
4
Graves' disease.格雷夫斯病。
Nat Rev Dis Primers. 2020 Jul 2;6(1):52. doi: 10.1038/s41572-020-0184-y.
5
Cross-cultural validation of the Retinopathy Treatment Satisfaction Questionnaire status version (RetTSQs) in Serbian community: a cross-sectional study.塞尔维亚社区中视网膜病变治疗满意度问卷状态版本(RetTSQs)的跨文化验证:一项横断面研究。
BMJ Open. 2020 Jan 19;10(1):e031236. doi: 10.1136/bmjopen-2019-031236.
6
Psychometric validation of three new condition-specific questionnaires to assess quality of life, symptoms and treatment satisfaction of patients with aortic aneurysm.三种新的特定病情问卷用于评估腹主动脉瘤患者生活质量、症状及治疗满意度的心理测量学验证
J Patient Rep Outcomes. 2019 May 16;3(1):29. doi: 10.1186/s41687-019-0119-0.
7
The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.左甲状腺素剂量调整的经济影响:CONTROL HE研究
Clin Drug Investig. 2017 Jan;37(1):71-83. doi: 10.1007/s40261-016-0462-3.
8
Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project.合并症、伴随用药及饮食作为影响左甲状腺素治疗的因素:CONTROL监测项目的结果
Drugs R D. 2016 Mar;16(1):53-68. doi: 10.1007/s40268-015-0116-6.
9
Undetected hypothyroidism: A rare dental diagnosis.未被检测出的甲状腺功能减退症:一种罕见的牙科诊断。
J Oral Maxillofac Pathol. 2014 May;18(2):315-9. doi: 10.4103/0973-029X.140922.
10
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.甲状腺功能减退症治疗指南:由美国甲状腺协会甲状腺激素替代特别工作组制定。
Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028.